Depression
Medications
Related eMedTV
Health Channels

Cymbalta Uses

Neuropathy

Peripheral diabetic neuropathy is one of several nerve disorders caused by diabetes. People with diabetes can, over time, have damage to nerves throughout the body. Peripheral diabetic neuropathy symptoms include numbness, pain, or other unpleasant feelings (such as burning or tingling) in the hands, feet, arms, or legs.
 
There are several ways that diabetes can cause nerve damage. Having high blood sugar for many years can damage the blood vessels that bring oxygen to some nerves. High blood sugar can also damage the covering on the nerves, called myelin. Damaged nerves may stop sending messages, or they may send messages too slowly or at the wrong times.
 
Cymbalta is approved to treat the pain associated with peripheral diabetic neuropathy in adults. While it can be effective for relieving diabetic nerve pain, Cymbalta does not reverse or slow down the nerve damage. The best way to prevent diabetic neuropathy or to slow down damage to the nerves is to keep your blood sugar as close to normal as possible (see Diabetic Neuropathy Prevention for more information). Also, diabetic foot care is especially important for people with peripheral diabetic neuropathy.
 
(Click Diabetic Neuropathy Treatment for more information about different treatment options for diabetic neuropathy.)
 

Generalized Anxiety Disorder (GAD)

Having this disorder means always anticipating disaster and often worrying excessively about health, money, family, or work. Sometimes, however, the source of the worry is hard to pinpoint. Simply the thought of getting through the day provokes anxiety.
 
There are several different treatments available for generalized anxiety disorder, including cognitive behavioral therapy and various types of medications. Cymbalta is one of those medications approved to treat generalized anxiety disorder.
 
(Cymbalta Uses Continued: Page 3)
Pages:

Previous 1 2 3 4 Next

Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation